(*corresponding author)

1. Terauchi N, Fujinami K, Shinoda K, Tsunoda K*, Hanazono G, Inomata K, Miyake Y

Transient macular dysfunction determined by focal macular electroretinogram.

Br J Ophthalmol. 2007 Dec;91(12):1709-10.


2. Fujinami K, Yokoi T, Hiraoka M, Nishina S, Azuma N*

Choroidal Neovascularization in Child following Laser Pointer-induced Macular Injury.

Jpn J Ophthalmol. 2010 Nov;54(6):631-3.


3. Fujinami K, Akahori M, Fukui M, Tsunoda K*, Iwata T, and Miyake Y

Stargardt Disease with Preserved Central Vision: identification of a putative novel mutation in ATP-binding cassette transporter gene.

Acta Ophthalmol. 2011 May;89(3):e297-8.


4. Fujinami K, Tsunoda K*, Hanazono G, Shinoda K, Ohde H, Miyake Y

Fundus Autofluorescence in Autosomal Dominant Occult Macular Dystrophy.

Arch Ophthalmol. 2011 May;129(5):597-602.


5. Tsunoda K*, Fujinami K, Miyake Y

Abnormal cone outer segment tip line even with normal photoreceptor inner/outer segment junction in optical coherence tomography images: indicator of cone dysfunction in acute zonal occult outer retinopathy.

Arch Ophthalmol. 2011 Aug;129(8):1099-101.


6. Fujinami K, Tsunoda K*, Nakamura M, Oguchi Y, Miyake Y

Oguchi’s Disease with Unusual Findings Associated with a Heterozygous Mutation in SAG gene.

Arch Ophthalmol. 2011 Oct;129(10):1375-6.


7. Chai Y, Yamazaki H, Fujinami K, Tsunoda K, Yamamoto S*

Case of Acute Zonal Occult Outer Retinopathy with Abnormal Visual Evoked Potentials.

Clin Ophthalmol. 2011;5:1235-41.


8. Tsunoda K*, Usui T, Hatase T, Fujinami K, Hanazono G, Shinoda K, Abe H, Miyake Y

Clinical characteristics of occult macular dystrophy in family with mutation of RP1L1.

Retina. 2012 Jun;32(6):1135-47.


9. Fujinami K, Lois N, Davidson AE, Mackay DS, Hogg CR, Stone EM, Tsunoda K, Tsubota K, Bunce C, Robson AG, Moore AT, Webster AR, Holder GE, Michaelides M*.

A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations.

Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13.


10. Fujinami K, Sergouniotis PI, Davidson AE, Mackay DS, Tsunoda K, Tsubota K, Robson AG, Holder GE, Moore AT, Michaelides M, Webster AR*.

The Clinical Effect of Homozygous ABCA4 Alleles in 18 Patients.

Ophthalmology. 2013 Nov;120(11):2324-31.


11. Fujinami K, Sergouniotis PI, Davidson AE, Wright G, Chana RK, Tsunoda K, Tsubota K, Egan CA, Robson AG, Moore AT, Holder GE, Michaelides M, Webster AR*.

Clinical and Molecular Analysis of Stargardt Disease with Preserved Foveal Structure and Function.

Am J Ophthalmol. 2013 Sep;156(3):487-501.e1.


12. Fujinami K, Tsunoda K*, Nakamura N, Kato Y, Noda T, Shinoda K, Tomita K, Hatase T, Usui T, Akahori M, Itabashi T, Iwata T, Ozawa Y, Tsubota K, Miyake Y.

Molecular Characteristics of Four Japanese Cases with KCNV2-retinopathy: Report of Novel Disease-causing Variants.

Mol Vis. 2013 Jul 20;19:1580-90.


13. Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K, Webster AR, Robson AG. Moore AT, Allikmets R*, Michaelides M*.

ABCA4 Gene Screening by Next-Generation Sequencing in a British Cohort.

Invest Ophthalmol Vis Sci. 2013 Oct 11;54(10):6662-74.


14. Fujinami K, Lois N, Mukherjee R, MacBain VA, Tsunoda K, Tsubota K, Stone EM, Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M*.

A Longitudinal Study of Stargardt Disease: Quantitative Assessment of Fundus Autofluorescence, Progression and Genotype Correlations.

Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90.


15. Fujinami K, Singh R, Carroll J, Zernant J, Allikmets R, Michaelides M, Moore AT*.

Fine Central Macular Dots Associated with Childhood-onset Stargardt Disease.

Acta Ophthalmol. 2014 Mar;92(2):e157-9.


16. Singh R, Fujinami K*, Chen LL, Michaelides M, Moore AT.

Longitudinal Follow-up of Siblings with a Discordant Stargardt Disease Phenotype.

Acta Ophthalmol. 2014 Jun;92(4):e331-2.


17. Singh R, Fujinami K*, Moore AT.

Branch Retinal Artery Occlusion Secondary to Prepapillary Arterial Loop.

Retin Cases Brief Rep. 2014 Spring;8(2):124-6.


18. Yamazaki R, Tsunoda K*, Fujinami K, Noda T, Tsubota K.

Fundus autofluorescence imaging in a patient with the juvenile form of galactosialidosis.

Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun;45(3):259-61.


19. Tanaka H, Fujinami K, Watanabe K, Noda T, Akiyama K*.

H.T. and K. F. contributed equally to this work and should be considered equivalent authors.

Haptic Breakage after Transscleral Fixation of a Single-Piece Acrylic Intraocular Lens.

Case Rep Ophthalmol. 2014 Jul 12;5(2):212-6.


20. Nishikawa Y, Fujinami K, Watanabe K, Noda T, Tsunoda K, Akiyama K.

Clinical course of focal choroidal excavation in Vogt-Koyanagi-Harada disease.

Y.N. and K. F. contributed equally to this work and should be considered equivalent authors.

Clin Ophthalmol. 2014 Dec 4;8:2461-5.


21. Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K, Robson AG, Holder GE, Allikmets R, Michaelides M*, Moore AT*.

Clinical and Molecular Characteristics of Childhood-onset Stargardt Disease

Ophthalmology. 2015 Feb;122(2):326-34.


22. Kato Y, Tsunoda K*, Fujinami K, Iwata T, Saga M, Oguchi Y.

Association of retinal artery and other inner retinal structures with distribution of tapetal-like reflex in Oguchi's disease.

Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2162-72.


23. Mizuno M, Fujinami K, Watanabe K, Akiyama K*.

Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage.

M.M. and K.F. contributed equally to this work and should be considered equivalent authors.

Case Rep Ophthalmol. 2015 Sep 15;6(3):328-32.


24. Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP*; Progression of Stargardt Disease Study Group (Fujinami K and others).

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.

Ophthalmology. 2016 Apr;123(4):817-28.


25. Hirakata T, Fujinami K, Watanabe K, Sasaki M, Noda T and Akiyama K*.

One-year outcomes of intravitreal aflibercept injections for age-related macular degeneration resistant to ranibizumab: rapid morphologic changes and subsequent visual improvement.

T.H. and K.F. contributed equally to this work and should be considered equivalent authors.

Clin Ophthalmol. 2016 May 26;10:969-77.


26. Kamoshita M, Fujinami K, Toda E, Tsubota K, Ozawa Y*.

Neuroprotective effect of activated 5'-adenosine monophosphate-activated protein kinase on cone system function during retinal inflammation. BMC Neurosci. 2016 Jun 10;17(1):32.


27. Nakamura N, Fujinami K, Mizuno Y, Noda T, Tsunoda K.

Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device.

Clin Ophthalmol. 2016 Jun 30;10:1175-85.


28. Nakanishi A, Ueno S*, Hayashi T, Katagiri S, Kominami T, Ito Y, Gekka T, Masuda Y, Tsuneoka H, Shinoda K, Hirakata A, Inoue M, Fujinami K, Tsunoda K, Iwata T, Terasaki H.

Clinical and genetic findings of autosomal recessive bestrophinopathy in Japanese cohort.

Am J Ophthalmol. 2016 Aug;168:86-94.


29. Kong X, Strauss RW, Michaelides M, Cideciyan AV, Sahel JA, Muñoz B, West S, Scholl HP*; ProgStar Study Group (Fujinami K and others).

Visual Acuity Loss and Associated Risk Factors in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2).

Ophthalmology. 2016 Sep;123(9):1887-97.


30. Fakin A, Robson AG, Fujinami K, Michaelides M, Chiang JP, Muñoz B, Holder GE, Webster AR*.

Phenotype and progression of retinal degeneration associated with nullizigosity of ABCA4.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4668-78.


31. Fujinami K, Kameya S, Kikuchi S, Ueno S, Kondo M, Hayashi T, Shinoda K, Machida S, Kuniyoshi K, Kawamura Y, Akahori M, Yoshitake K, Katagiri S, Nakanishi A, Sakuramoto H, Ozawa Y, Tsubota K, Yamaki K, Mizota A, Terasaki H, Miyake Y, Iwata T, Tsunoda K*.

K.F. and K.S. contributed equally to this work and should be considered equivalent authors.

Novel RP1L1 Variants and Genotype-Photoreceptor Microstructural Phenotype Associations in Cohort of Japanese Patients with Occult Macular Dystrophy.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4837-46.


32. Akiyama K*, Fujinami K, Watanabe K, Tsunoda K, Noda T.

Internal Limiting Membrane Peeling to Prevent Post-Vitrectomy Epiretinal Membrane Development in Retinal Detachment

Am J Ophthalmol. 2016 Nov;171:1-10.


33. Fakin A, Robson AG, Chiang JP, Fujinami K, Moore AT, Michaelides M, Holder GE, Webster AR*.

The effect on retinal structure and function of 15 specific ABCA4 mutations - a detailed

examination of 82 hemizygous patients.

Invest Ophthalmol Vis Sci. 2016; 6 Nov 1;57(14):5963-5973.


34. Tanna P, Strauss RW, Fujinami K, Michaelides M*.

Stargardt Disease – Clinical Features, Molecular Genetics, Animal Models and Therapeutic Options.

Br J Ophthalmol. 2017 Jan;101(1):25-30.


35. Schönbach EM∗, Ibrahim MA∗, Strauss RW, Birch DG, Cideciyan AV, Hahn GA, Ho A, Kong X, Nasser F, Sunness JS, Zrenner E, Sadda SR, West SK, Scholl HP; ProgStar Study Group (Fujinami K and others).

EMS, MAI, and RWS contributed equally to this work and should be considered equivalent authors.

Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease; ProgStar Report No. 3

Opthalmology Ret. 2017 Jan; 1(1):68-76.

Division for Vision Research, National Institute of Sensory Organs

© 2016 by Kaoru Fujinami. Proudly created with

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey

UCL Institute of Ophthalmology associated with Moorfields Eye Hospital